Home Markets AstraZeneca rejoins leading U.S. drug lobby group after two-year absence AstraZeneca rejoins leading U.S. drug lobby group after two-year absence Andrew M Apr 22, 2025 comments off Tweet on Twitter Share on Facebook Google+ Pinterest Original source: https://www.investing.com/news/stock-market-news/astrazeneca-rejoins-leading-us-drug-lobby-group-after-twoyear-absence-3996772 Market Updates